跳至主要内容
临床试验/NCT01509287
NCT01509287已完成不适用

Metabolic Screening in Patients With Donnai-Barrow Syndrome

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
78
试验地点
1
主要终点
measures of blood sugar, cholesterol, vitamins A and D, and other compounds

研究概览

简要总结

This study focuses on the genetics and metabolism of Donnai-Barrow Syndrome (DBS).

详细描述

The purpose of this study is to better understand the role of certain nutrients and vitamins in promoting the healthy development of individuals with Donnai-Barrow Syndrome. The investigators hope that the information gained by studying the metabolism of children with Donnai-Barrow Syndrome and their family members will lead to significant advances in the treatment of this disease.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • All individuals affected with Donnai-Barrow Syndrome

排除标准

  • 未提供

结局指标

主要结局

measures of blood sugar, cholesterol, vitamins A and D, and other compounds

时间窗: 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Barbara R. Pober

Principal Investigator and Clinical Geneticist

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验